Enterogermina Invites Physicist and Ig Nobel Winner to Develop a Toast That Defies Murphy's Law
Sanofi (SNYNF) Gets a Buy From UBS
Research Alert: CFRA Keeps Buy Opinion On Ads Of Sanofi
Goldman Sachs Reaffirms Their Hold Rating on Sanofi (SNYNF)
Sanofi Reports Strong Q1 2025 Performance
Sanofi and Sobi Extend Their Partnership With the World Federation of Hemophilia Humanitarian Aid Program
Sanofi Invests €15 Mln In Innate Pharma To Support Pipeline And Extend Cash Runway
Sanofi (SNY) Q1 2025 Earnings Call Transcript Summary
Sanofi Axes Development of Oral TNF Inhibitor as Monotherapy Following Phase II Fail
6-K: Strong Q1 Performance and 2025 Guidance Confirmed
French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit
Sanofi Proposes Annual Dividend of €3.92, a Hike of 4.26% From Prior Dividend
Sector Update: Health Care Stocks Steady Pre-Bell Thursday
EU Pharma Majors Sanofi, Roche Trade Flat After Reiterated Guidance
TD Cowen Maintains Sanofi(SNY.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Sanofi (SNY)
US Stock Market Preview | All three Equity Index futures drop, Google (GOOGL.US) and Intel (INTC.US) release Earnings Reports after hours.
On April 24th (Thursday) in Pre-Market Trading, all three major U.S. equity index futures fell.
Barclays Keeps Their Buy Rating on Sanofi (SNYNF)
Sanofi Reports Q1 IRFS EPS EUR 1.52 Vs. EUR 0.91 Last Year
Sanofi Expects Closing of Opella Stake Sale in Q2